MOH — authorised 16 February 2001
- Marketing authorisation holder: NOVARTIS
- Status: likely_approved
MOH authorised Foradil on 16 February 2001
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 16 February 2001.
NOVARTIS holds the Israeli marketing authorisation.